Navigation Links
What U.S. Doctors Know That Has Not Yet Reached China

NEW YORK, Oct. 22, 2013 /PRNewswire/ -- Fibromyalgia (FM), a disorder now taken seriously in the United States after decades of misinformation and misdiagnosis, is still largely misunderstood and underdiagnosed by physicians in China. A recent national survey of Chinese rheumatologists revealed they have a lower awareness of FM compared with colleagues in Western countries. Sadly for China's patients with FM—a chronic disorder characterized by widespread musculoskeletal pain and fatigue—the dismissive attitude formerly directed at U.S. patients ("It's all in your mind!") is now being encountered by Chinese patients, just before they walk out of the doctor's office with no relief in sight.

An anonymous survey was conducted among a nationwide sample of Chinese rheumatologists at the 15th National Rheumatology Conference in 2010, with results published in the International Journal of Rheumatic Diseases this year. Of more than 700 respondents, 80 percent reported difficulties in treating FM patients. Nearly all—90.8 percent—mistakenly believed that the prognosis of FM patients was usually benign, and nearly 30 percent believed FM was only a psychological disorder. The investigators concluded that "awareness and perception of FM are still low among Chinese rheumatologists." There was some good news from the survey, however: "Our data also showed that most Chinese rheumatologists were eager for continuing medical education on FM."

In the U.S., people with FM who complained of "pain all over their bodies, constant fatigue and poor sleep" are no longer being told all they have is a psychological condition. Thanks to advanced medical technologies, most doctors here—both rheumatologists and other specialists—now have a deeper understanding as to how FM affects the body. However, with five million affected people in the U.S., the challenge is that treatment remains elusive. And there are still outstanding challenges as only half of this population is being treated.

Enter Seth Lederman, M.D., President and CEO of NYC-based TONIX Pharmaceuticals. The company's formulation, TNX-102 SL, is designed to help change FM treatment for millions of sufferers. Dr. Lederman and his team believe the key to easing the pain and suffering is enabling these patients to break the vicious cycle between poor sleep at night and pain during the day.

TONIX has taken cyclobenzaprine—an FDA-approved muscle relaxant that's been on the market for 35 years—and reformulated it as an under-the-tongue tablet taken at bedtime. This allows cyclobenzaprine to be taken up into the bloodstream rapidly, setting the tone for restorative sleep, which has been shown to mitigate pain experienced in FM.

Tonix recently announced the initiation of its Bedtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) clinical trial, which is the first of two pivotal trials for TNX-102 SL 2.8 mg tablets, in patients with FM. 

For more on TNX-102 SL and the BESTFIT trial, visit

Contact:  Laura Radocaj, Dian Griesel Int'l., 212.825.3210

SOURCE TONIX Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
2. Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online
3. Doctors at St. Josephs Hospital Stopping Atrial Fibrillation Cold
4. New Program Has Doctors, Patients Learn Together As Traditional Relationship Changes Forever
5. Eaton Scientific Discusses Positive Anecdotal Feedback from Pharmacist Compounding Homatropine for Doctors Treating Patients Experiencing Hot Flash Symptoms in the Beverley Hills and Los Angeles Area.
6. Latest Trend in Drug Manufacturer Sales Allows Doctors to Obtain Product Samples Online
7. Africa Needs Engineers as Much as Doctors to Save Lives, says South African Entrepreneur
8. Africa Needs Engineers as Much as Doctors to Save Lives, says South African Industrialist
9. The Japanese Cancer Association and Debiopharm Group Present Doctors Oshima and Tanaka with the 2012 JCA-Mauvernay Award for their Innovative and Outstanding Cancer Research
10. WebMD Study: U.S. Doctors Deeply Divided on Many Matters of Ethical Ambiguity
11. For Drug Manufacturers Bringing a New Product to Market, Gaining the Support of Influential Doctors Is a Mission-Critical Priority
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... NORTHBROOK, Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the ... joins Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... appointed General Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... Pa. , June 23, 2016 The ... in an outpatient dialysis facility.  Treatments are usually 3 ... 6 hours per visit, including travel time, equipment preparation ... a patient, but especially grueling for patients who are ... of a skilled nursing and rehabilitation centers for some ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):